Fate Therapeutics
(FATE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,622 | 41,249 | 44,920 | 36,056 | 37,909 |
| Marketable Securities | 174,801 | 181,581 | 195,505 | 243,012 | 259,014 |
| Receivables | 682 | 1,395 | 2,406 | 3,539 | 4,127 |
| TOTAL | $221,251 | $230,397 | $248,217 | $291,909 | $310,294 |
| Non-Current Assets | |||||
| PPE Net | 59,475 | 61,097 | 62,762 | 64,384 | 82,392 |
| Investments And Advances | 10,305 | 26,097 | 32,286 | 27,657 | 33,607 |
| Other Non-Current Assets | 52,640 | 54,041 | 55,405 | 56,744 | 68,677 |
| TOTAL | $122,420 | $141,235 | $150,453 | $148,785 | $184,676 |
| Total Assets | $343,671 | $371,632 | $398,670 | $440,694 | $494,970 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,504 | 4,040 | 4,190 | 9,365 | 6,349 |
| Accrued Expenses | 17,571 | 18,182 | 17,213 | 21,348 | 23,580 |
| Other current liabilities | 2,280 | 795 | N/A | N/A | N/A |
| TOTAL | $28,111 | $28,673 | $28,159 | $38,522 | $37,422 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 5 | N/A | 212 | 393 | 600 |
| Other Non-Current Liabilities | 81,494 | 81,595 | 82,102 | 83,446 | 95,222 |
| TOTAL | $81,494 | $81,595 | $82,102 | $83,446 | $95,222 |
| Total Liabilities | $109,605 | $110,268 | $110,261 | $121,968 | $132,644 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 115,352 | 115,330 | 114,633 | 114,597 | 113,894 |
| Common Shares | 115 | 115 | 115 | 114 | 114 |
| Retained earnings | -1,501,935 | -1,469,685 | -1,435,615 | -1,397,994 | -1,345,841 |
| Other shareholders' equity | 156 | 65 | 194 | 271 | 838 |
| TOTAL | $234,066 | $261,364 | $288,409 | $318,726 | $362,326 |
| Total Liabilities And Equity | $343,671 | $371,632 | $398,670 | $440,694 | $494,970 |